Related Experiment Video

Updated: Aug 14, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

Antidepressant action: to the nucleus and beyond

Jessica E Malberg1, Julie A Blendy

  • 1Neuroscience Discovery, Wyeth Research, Princeton, NJ 08543, USA. malberj1@wyeth.com

Trends in Pharmacological Sciences
|October 26, 2005
PubMed

Insights

Antidepressant efficacy requires long-term molecular regulation, moving beyond acute effects to focus on transcriptional regulators like CREB and neurogenesis. Research now links these pathways to depression symptom alleviation.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Psychiatry

Background:

  • Antidepressant drug mechanisms remain poorly understood despite decades of research.
  • The 2-6 week therapeutic lag suggests long-term molecular adaptations are crucial for efficacy.
  • Research has shifted from acute monoamine effects to long-term regulators and neurogenesis.

Purpose of the Study:

  • To elucidate the long-term molecular mechanisms underlying antidepressant drug action.
  • To investigate the role of cAMP response element-binding protein (CREB) and trophic factors in antidepressant effects.
  • To understand the connection between antidepressant-induced neurogenesis and depression symptom relief.

Main Methods:

  • Focus on long-term transcriptional regulation.
  • Analysis of signaling pathways involving CREB, BDNF, and IGF.
  • Investigating antidepressant-induced neurogenesis.

Main Results:

  • Long-term regulation of molecules like CREB and trophic factors is essential for antidepressant efficacy.
  • Antidepressant-induced neurogenesis offers a novel mechanism for therapeutic effects.
  • Understanding the coupling of CREB and trophic factor pathways to neurogenesis is key.

Conclusions:

  • Antidepressant action involves complex, long-term molecular and cellular changes, including neurogenesis.
  • Further research is needed to link molecular and cellular alterations to behavioral improvements in depression.
  • Targeting CREB and neurotrophic pathways may offer new therapeutic strategies for depression.

More Related Videos

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Related Concept Videos

G-protein Coupled Receptors01:21

G-protein Coupled Receptors

G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...